Search Results - "Majer, I."

Associated production of a Higgs boson decaying into bottom quarks and a weak vector boson decaying leptonically at NNLO in QCD by Gauld, R., Ridder, A. Gehrmann-De, Glover, E.W.N., Huss, A., Majer, I.

“…A bstract We present the calculation of next-to-next-to-leading order (NNLO) corrections in perturbative QCD for the production of a Higgs boson decaying into…”
Get full text

Transverse momentum distributions in low-mass Drell-Yan lepton pair production at NNLO QCD by Gauld, R., Gehrmann–De Ridder, A., Gehrmann, T., Glover, E.W.N., Huss, A., Majer, I., Rodriguez Garcia, A.

“…The production of lepton pairs at low invariant mass and finite transverse momentum resolves QCD dynamics at the boundary between the perturbative and…”
Get full text

VH + jet production in hadron-hadron collisions up to order αs3 in perturbative QCD by Gauld, R., Gehrmann-De Ridder, A., Glover, E. W. N., Huss, A., Majer, I.

“…A bstract We present precise predictions for the hadronic production of an on-shell Higgs boson in association with a leptonically decaying gauge boson and a…”
Get full text

VH + jet production in hadron-hadron collisions up to order $$ {\alpha}_{\mathrm{s}}^3 $$ in perturbative QCD by Gauld, R., Gehrmann-De Ridder, A., Glover, E. W. N., Huss, A., Majer, I.

“…A bstract We present precise predictions for the hadronic production of an on-shell Higgs boson in association with a leptonically decaying gauge boson and a…”
Get full text

Predictions for Z-Boson Production in Association with a b-Jet at O(α_{s}^{3}) by Gauld, R, Ridder, A Gehrmann-De, Glover, E W N, Huss, A, Majer, I

“…Precise predictions are provided for the production of a Z boson and a b-jet in hadron-hadron collisions within the framework of perturbative QCD, at…”
Get full text

Precise predictions for WH+jet production at the LHC by Gauld, R., Gehrmann-De Ridder, A., Glover, E.W.N., Huss, A., Majer, I.

“…We present precise predictions for the production of a Higgs boson in association with a hadronic jet and a W boson at hadron colliders. The behaviour of QCD…”
Get full text

Socioeconomic inequalities in life and health expectancies around official retirement age in 10 Western-European countries by Majer, I M, Nusselder, W J, Mackenbach, J P, Kunst, A E

“…BackgroundDiscussions on raising pension eligibility age focus more on improvement in life expectancy (LE) and health expectancy measures than on socioeconomic…”
Get full text

TREM-1 and TREM-2 Expression on CD14+ Cells in Bronchoalveolar Lavage Fluid in Pulmonary Sarcoidosis and Hypersensitivity Pneumonitis in the Context of T Cell Immune Response by Jonner, I., Konig, B., Bucova, Maria, Majer, Ivan, Sandor, F., Tedlova, Eva, Szaboova, K., Tibenska, Elena, Ganovska, M., Urban, J., Suchankova, Magda, Bobovcak, M.

“…Background. Sarcoidosis and hypersensitivity pneumonitis (HP) are immunologically mediated processes caused by hypersensitivity reaction accompanied by similar…”
Get full text

The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders by Konecny, M, Markus, J, Waczulikova, I, Dolesova, L, Kozlova, R, Repiska, V, Novosadova, H, Majer, I

“…Methylation of the cytosine residues within the CpG dinucleotides plays an important role in the fundamental cellular processes, human diseases and even…”
Get more information

Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer by Z.A. Wainberg, P.C. Enzinger, S. Qin, K. Yamaguchi, J. Wang, X. Zhou, A. Gnanasakthy, K. Taylor, A. Yusuf, I. Majer, A. Jamotte, Y.-K. Kang

“…Background: In the phase II, randomized, double-blind FIGHT trial (NCT03694522), treatment with bemarituzumab plus mFOLFOX6 resulted in improvements in…”
Get full text

Increased Antifungal Antibodies in Bronchoalveolar Lavage Fluid and Serum in Pulmonary Sarcoidosis by Suchankova, M., Paulovicova, E., Paulovicova, L., Majer, I., Tedlova, E., Novosadova, H., Tibenska, E., Tedla, M., Bucova, M.

“…The recent studies suggest a role of fungi in development of sarcoidosis. Moreover, the immune response in sarcoidosis and fungal infection shows a striking…”
Get full text

HEALTH CARE RESOURCE USE AND COST IN RHEUMATOID ARTHRITIS PATIENTS ASSOCIATED WITH DIFFERENT BDMARD TREATMENT LINES: A GERMAN CLAIMS DATA ANALYSIS BASED ON 3624 PATIENTS by Wilke, T, Lee, S.C, Maywald, U, Fuchs, A, Mueller, S, Majer, I, Heisen, M

Get full text

A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis by Heeg, B, Majer, I, Stephens, J.M, Tarallo, M

Get full text

Newer diagnostic methods in bronchology by Majer, I

Get more information

Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients by Dearden, L, Majer, I, Heeg, B, Liwing, J, Sandstrom, K, Diels, J

Get full text

Diagnostic value of TREM-1 and TREM-2 expression in bronchoalveolar lavage fluid in sarcoidosis and other lung diseases by Bucova, M, Suchankova, M, Tibenska, E, Majer, I, Novosadova, H, Urban, S

“…Triggering receptors expressed on myelocytes (TREM) belong to new molecules with a great role in innate immune system and inflammation. While TREM-1 is known…”
Get full text

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial by Majer, I M, Gelderblom, H, van den Hout, W B, Gray, E, Verheggen, B G

“…Surgical resection of gastrointestinal stromal tumour (GIST) is rarely curative in patients at high risk of tumour recurrence and therefore 1 year of…”
Get more information

Genotyping of EGFR Mutations from Bronchial Cytological Specimens in Slovakian Lung Cancer Patients by Baluchova, K, Zahradnikova, M, Bakes, P, Trubacova, S, Novosadova, H, Halasova, E, Majer, I, Hlavcak, P

“…Non-small cell lung cancer (NSCLC) is a histologically and molecularly heterogeneous disease predominating in Slovakia among newly diagnosed oncological…”
Get more information

sTREM-1 in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis, effect of smoking and inflammation by Suchankova, M, Bucova, M, E, Tibenska, Demian, J, Majer, I, Novosadova, H, Tedlova, E, Durmanova, V, Paulovicova, E

“…Soluble TREM-1 (sTREM-1; Triggering receptor expressed on myelocytes) is a new inflammatory marker indicating the intensity of myeloid cells activation and the…”
Get full text

Complete extirpation of benign breast lesions with an ultrasound‐guided vacuum biopsy system by Krainick‐Strobel, U., Huber, B., Majer, I., Bergmann, A., Gall, C., Gruber, I., Hoffmann, J., Paepke, S., Peisker, U., Walz‐Mattmüller, R., Siegmann, K., Wallwiener, D., Hahn, M.

“…Objectives To investigate whether ultrasound‐guided vacuum biopsy (VB) with curative intent is suitable for the complete extirpation of selected…”
Get full text